Clinical Trials
Wednesday, October 5th, 2016
J Am Heart Assoc, 24 August 2015 Background The latest guidelines do not make clear recommendations on the selection of antiplatelet therapies for long-term secondary prevention of stroke. We aimed to integrate the available evidence to create hierarchies of the comparative efficacy and safety of long-term antiplatelet therapies after ischemic stroke or transient ischemic attack. … Conclusions Long-term […]
Atrial Fibrillation
Wednesday, October 5th, 2016
J Am Heart Assoc, 14 September 2016 Background Alcohol consumption has been associated with atrial fibrillation (AF) in several epidemiologic studies, but the underlying mechanisms remain unknown. We sought to test the hypothesis that an atrial myopathy, manifested by echocardiographic left atrial enlargement, explains the association between chronic alcohol use and AF. … Conclusions Our study of a […]
Atrial Fibrillation
Wednesday, October 5th, 2016
J Am Heart Assoc, 9 September 2016 Background Several studies have investigated the impact of body mass index (BMI) on the prognosis of atrial fibrillation, but the results remain controversial. We sought to estimate the association of BMI with atrial fibrillation–related outcomes. … Conclusions Underweight BMI is associated with an increased risk of stroke or systemic embolism, cardiovascular […]
Atrial Fibrillation
Wednesday, October 5th, 2016
BMJ, 6 September 2016 Objective To quantify the association between atrial fibrillation and cardiovascular disease, renal disease, and death. … Conclusions Atrial fibrillation is associated with an increased risk of death and an increased risk of cardiovascular and renal disease. Interventions aimed at reducing outcomes beyond stroke are warranted in patients with atrial fibrillation. Read more.
Atrial Fibrillation
Wednesday, October 5th, 2016
Lancet, 18 August 2016 Atrial fibrillation affects 33 million individuals worldwide,and increases the risk of stroke, heart failure, and death; it also impairs quality of life. The goals of care in atrial fibrillation include the prevention of stroke, control of the ventricular rate, and minimisation of symptoms to improve quality of life. A three-part clinical Series summarises […]
Atrial Fibrillation
Wednesday, October 5th, 2016
Circulation, 26 July 2016 Atrial fibrillation (AF) is the most common arrhythmia encountered by cardiologists and is a major cause of morbidity and mortality. Risk factors for AF include age, male sex, genetic predisposition, hypertension, diabetes mellitus, sleep apnea, obesity, excessive alcohol, smoking, hyperthyroidism, pulmonary disease, air pollution, heart failure, and possibly excessive exercise. The management of […]
Atrial Fibrillation
Wednesday, October 5th, 2016
Circ Cardiovasc Qual Outcomes, 27 June 2016 In the summer of 2015, the ACC/AHA convened the writing committee to begin the process of revising the existing atrial fibrillation (AF) and atrial flutter measure set that was released in 2008 and for which implementation notes had been issued in 2011. The writing committee also was charged with the […]
